Data as of Jan 29
| +0.15 / +0.61%|
The 10 analysts offering 12-month price forecasts for BioMed Realty Trust Inc have a median target of 23.50, with a high estimate of 28.00 and a low estimate of 22.50. The median estimate represents a -5.43% decrease from the last price of 24.85.
The current consensus among 12 polled investment analysts is to Buy stock in BioMed Realty Trust Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.